Changes are on the cards for some breast cancer patients.
Pharmac is consulting on a drug switch proposal to replace the current expired one.
Herzuma is said to be more safe and cost effective, but at what there are concerns about whether all patients will be suited to it.
Breast Cancer Foundation's Research and Strategics Manager, Adele Gautier, joined Kate Hawkesby.
LISTEN ABOVE

Leeann Watson: Business Canterbury CEO on the number of international business delegates visiting New Zealand rising by 50%
02:52

Catherine Beard: Business NZ Advocacy Director on the Government's loan scheme to help businesses transition from natural gas
02:58

Todd Barberel: WellingtonNZ General Manager Destination and Marketing on a drop in cruise visits
02:44